Circulating tumor cells in patients with cervical cancer undergoing chemoradiotherapy combined with brachytherapy.
Ontology highlight
ABSTRACT: Circulating tumor cells (CTCs) have significant potential to become an important tool for monitoring the effects of treatment in solid tumors. The present study reports the occurance of CTCs in cervical cancer (CC) patients during radical chemoradiotherapy (CRT), including brachytherapy (BRT), and during the follow-up period. Patients diagnosed with CC treated with radical CRT were included in the study (n=30). A total of 167 CTC-tests (MetaCell®) were provided at predefined testing time points during the study follow-up (e.g., before CRT, after CRT, every three months of follow-up). In parallel with CTC-testing, SCC-Ag were measured to compare their predictive values during treatment. CTCs were present in 96% (25/26) of patients at the time of diagnosis and in 61% (14/23) after
SUBMITTER: Reginacova K
PROVIDER: S-EPMC11301293 | biostudies-literature | 2024
REPOSITORIES: biostudies-literature
ACCESS DATA